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Abstract 
Objectives: To assess the implications of variation in Metabolic Syndrome (MS) definition 
(biochemical and anthropometric indicators) on MS prevalence estimates in a population 
of overweight and mildly obese children.  
Design: Cross-sectional study 5 
Subjects: Ninety-nine (64 girls) overweight or mildly obese, but otherwise healthy, pre-
pubertal 6 to 9 year olds recruited for a randomised controlled trial of weight management 
Measures: Height, weight and waist circumference were measured with BMI and waist z-
scores calculated.  Fasting cholesterol and fractions, glucose and insulin were measured, 
together with systolic and diastolic blood pressure (BP). Anthropometric and metabolic 10 
indicators were classified as normal or elevated using adult or child-specific cut points with 
clustering of MS indicators also assessed using 2 adult and 3 child-specific definitions. 
Results: Zero to 4% of subjects were classified with MS when adult definitions were 
applied.  This increased to between 39-60% using child-specific definitions, varying 
according to whether hyperinsulinaemia was central to the MS classification.  Systolic BP, 15 
triglycerides, total cholesterol, high density lipoprotein cholesterol and waist z-score 
increased across insulin quartiles (p<0.05).  The use of body mass index and waist 
circumference in the MS definition classified the same subjects.    
Conclusions:  The classification of MS in children depends strongly on the definition 
chosen, with MS prevalence estimates higher if insulin is part of the definition and child-20 
specific cut points for metabolic indicators are used.  Hyperinsulinaemia and MS are 
common consequences of childhood obesity but they are not commonly part of the 
assessment or management plan for weight management in children.  There is a need for 
the establishment of normal insulin ranges and consistent definition of MS in childhood 
and adolescence. 25 
Keywords: lipids; insulin; childhood; obesity; central adiposity; blood pressure; waist 
circumference; body mass index. 
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Introduction 
Childhood overweight is increasingly common worldwide (1-3) as are the consequences 30 
that include increased risk of later cardiovascular disease and diabetes (4, 5).  The 
Metabolic Syndrome (MS) describes the clustering of central obesity, dyslipidaemia (raised 
triglycerides and/or low high density lipoprotein), hyperinsulinaemia, impaired glucose 
tolerance and elevated blood pressure, and is a clear indicator of adult morbidity (6). The 
metabolic indicators of MS are present in early life, increase with severity of paediatric 35 
obesity and track over the lifecycle (7-9).  While MS is a well recognised phenomenon, 
identification is problematic as definitions are numerous and there are no accepted 
definitions in adolescents and children.   
 
In adults, the definition of MS varies in terms of the indicators featured and cut points used 40 
(10-12). Two (10, 12) of the three common definitions include measures of insulin 
resistance, reflecting the proposed causal or mediating role insulin action plays in the 
development of MS (13, 14).  In the paediatric literature there is no single definition of MS 
(15-17).  Barriers to a consistent, accepted definition for children and adolescents include: 
use of adult cut points or a single set of cut points for all ages of childhood; the fact that 45 
disturbances seen in the metabolic indicators in most children are quantitatively moderate; 
lack of a normal range for insulin concentration across childhood; the insulin resistance of 
puberty; and lack of central obesity (waist) cut points linked to obesity morbidity or MS for 
children.  If hyperinsulinaemia alone is used as a marker of MS in children (18), it ignores 
the clustering of several metabolic indicators which is potentially of greater clinical 50 
significance.  
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The worsening childhood obesity epidemic and the long term health risks for both obese 
children and adults highlight the need for a workable, consistent definition of MS in 
children to enable investigation of prevalence and both short and long term health 
outcomes.  Population studies of MS in children and adolescents have used inconsistent 55 
and arbitrary MS definitions, included all pubertal stages and a wide age range (15-17). No 
study to date has focused on pre-pubertal children and few on obese populations.  The 
objective of this study is to assess the implications of variation in MS definition (both 
biochemical and anthropometric indicators) on MS prevalence estimates in a population of 
overweight and mildly obese pre-pubertal six to nine year olds. The secondary objective is 60 
to explore how the indicators of metabolic syndrome vary by insulin concentration and 
degree of obesity. 
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Methods 
Subjects 
The subjects (N=99) were baseline participants in a randomised controlled trial for the 65 
management of childhood overweight. They were recruited from metropolitan Adelaide, 
South Australia, via media publicity, health professional referral and school newsletter 
information.  Study inclusion criteria were: age six to nine years (up to 10th birthday); 
overweight (based on body mass index [BMI], age and gender specific cut-points 
developed by Cole et al (19)) or mildly obese (BMI z-score <3.5, based on UK BMI 70 
reference curves (20)); pre-pubertal (Tanner Stage 1 (21)) and care-giver able to attend 
sessions and read and understand English. Exclusion criteria were: sibling enrolled in the 
study, known syndromal cause of obesity, medications influencing weight gain or loss, 
physical or developmental disability, chronic illness, and significant dietary restriction. 
Eligibility was initially assessed via telephone interview and confirmed at a screen by a 75 
medical practitioner.  Study information sheets were provided and informed written 
consent obtained from both the parent and the child.  This study was approved by the 
Flinders Clinical Research Ethics Committee and the Women’s and Children’s Hospital’s 
Ethics Committee, Adelaide, Australia.    
 80 
Measurements 
All measurements were taken by a single trained observer at two sites (Flinders Medical 
Centre and Women’s and Children’s Hospital).  Height, weight and waist circumference 
were measured with subjects lightly clothed and without shoes.  Height to the nearest 1.0 
mm was measured with a TrumeterTM stadiometer (Manchester, UK) and weight to the 85 
nearest 0.1 kg with SECATM electronic scales (Hamburg, Germany). The waist 
circumference measurement was taken with subjects in a standing position, midway 
between the tenth rib and the iliac crest, using a non-elastic flexible tape, and recorded to 
the nearest mm. 
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Blood was collected via venepuncture following an overnight fast.  Fasting glucose, total 90 
cholesterol (TC), high density lipoprotein cholesterol (HDL-C) and triglycerides (TG) were 
determined within 4 hours by standard automotive techniques using a Synchron CX5 Pro 
analyser (Beckman Coulter Inc, Fullerton, USA) in the clinical diagnostic laboratory, 
Division of Laboratory Medicine, Women’s and Children’s Hospital, Adelaide.  Low density 
lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation as 95 
Cholesterol – (HDL + Triglycerides/2.2) (11). Immediately following sample collection, 
plasma was drawn off and stored at –70oC until fasting serum insulin were measured in 
batched samples in the Diagnostic Laboratory Department of Endocrinology Royal Prince 
Alfred Hospital (RPAH), Sydney by radio-immunoassay using the Linco Human Insulin 
Specific Assay Kit (Linco Research Inc, Missouri USA). Blood pressure was measured on 100 
the right arm using a DinamapTM automated blood pressure monitor (GE Healthcare, UK).  
A variety of cuff-sizes were used (small-adult was the most common) to ensure that the 
length of the bladder completely encircled the arm and the width was at least two-thirds 
the length of the upper arm (22). A single measurement was taken after supine rest for 10 
minutes following collection of the blood sample and anthropometric measures.  105 
 
Definition of metabolic syndrome (MS)  
Subjects were classified as displaying MS according to six definitions, two adult and four 
child-specific using age-adjusted cut points. The definitions used to classify MS in adults 
were included as they have already been applied and compared in adolescent populations 110 
and would potentially provide the easiest use in the clinical setting (23).  The relevant 
indicators and associated cut points are shown in Table 1. Four of the definitions (1 adult, 
3 child) include fasting insulin resistance and at least two other abnormal indicators and 
are defined as follows: 
 Definition 1 is the European Group for the Study of Insulin Resistance (EGIR) (10) 115 
adult definition which includes waist circumference as a measure of central obesity. As no 
 6
cut point for fasting insulin is given in this definition, the upper 95% confidence limit 
(51pmol/L) of a normal volunteer adult sample from the Endocrinology Laboratory, Royal 
Prince Alfred Hospital, Sydney (N= 148) was used.  
 Definition 2 is the US National Cholesterol Education Program (NCEP) adult 120 
definition which includes abnormalities in any three of glucose, triglycerides, HDL-C, 
systolic BP (SBP) and waist circumference (insulin not included) (11).   
 Definition 3 is that used by Lambert et al (2004) which includes fasting insulin (15). 
They used the 75th percentiles of a Canadian community based sample of 783 subjects 
aged nine years, as cut points for each indicator except BMI for which the 85th percentile 125 
was used.  As the actual cut point values for SBP were not quoted, US percentiles for age 
(to the nearest year), gender and height were used in this study with the 95th percentile an 
indicator of high SBP (24).  An adjustment was also required for BMI as cut point values 
were only quoted for 9 year-olds and our sample included six to nine-year-olds. The z-
scores of the quoted BMI values were determined using UK reference curves (20) (boys 130 
1.77, girls 1.51) and used as the BMI cut point value for all ages.   
 Definition 4 is a modification of Definition 3 replacing the cut point for TG with the 
75th percentile from the US Lipid Research Prevalence Study and the cut point for HDL-C 
cholesterol with recommendations from the American Academy of Paediatrics (25) using a 
lipid conversion factor of mg/dL x 0.0259.  135 
 Definition 5 is a modification of Definition 1 replacing adult cut points with child-
specific cut points as per Definition 4 and using the 91st percentile by age and gender for 
waist as a measure of central adiposity  which in adults is the adiposity measure used to 
define MS. The 91st and 98th centiles are arbitrary but were chosen as they have 
previously been used in studies of young people and are similar to the cut points used to 140 
determine central overweight and obesity based on BMI (26, 27).   
 Definition 6 is a modification of the NCEP definition (Definition 2) using the same 
cut points as per Definition 5. 
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Data analysis 
Analyses were performed using SPSS for Windows version 11.0 (SPSS Inc, Chicago). 145 
The distribution of all indicators was normal except for triglycerides.  Data are expressed 
as mean (SD) and proportions of the sample unless otherwise specified. BMI was 
calculated as weight divided by height squared (kg/m2) and the subject’s BMI z-score was 
calculated using UK reference data (20) provided as a computer program (Child Growth 
Foundation, London UK). This package allows calculation of BMI z-score using decimal 150 
age. Subjects were classified as overweight or obese using BMI age and gender specific 
cut points developed by Cole et al (19). Each subject’s waist circumference was converted 
to a z-score using UK reference data and subjects were classified as being centrally 
overweight or obese if their waist measurement exceeded the 91st or 98th percentile (z- 
scores 1.34 or 2.05) respectively (27).  155 
 
Using the cut points defined in Table 1, the absence or presence of each metabolic 
indicator was determined and the proportion of subjects identified with MS according to 
each of the definitions determined. In addition, the presence of elevated total and LDL-C 
cholesterol was determined based on recommendations from the American Academy of 160 
Paediatrics (25). The presence of elevated DBP was determined as for SBP as a value 
above the 95th US percentiles for age (to the nearest year), gender and height (24).  
 
ANOVA was used to compare all indicators by quartile of insulin, BMI z-score and waist z-
score. Chi-squared analysis was used for comparisons of prevalence of MS by gender, 165 
weight status, and quartiles of BMI and waist z-scores. As the definitions for overweight 
and obesity in children used here have not been related to health outcomes, subjects were 
reclassified with MS using definitions 3 and 4, if two of the criteria, excluding BMI, were 
met and BMI and waist z-scores were compared by t-test between those with MS and 
those without. A significance level of 0.05 was used. 170 
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Results  
Subject anthropometric measurements are shown in Table 2. Compared with females, 
males were older, taller, heavier and had greater waist circumference and waist z-score 
(all p<0.05) but there was no difference between the sexes for BMI or BMI z-score (p=0.54 
and 0.35 respectively).  Using the BMI cut-points published by Cole et al (19), all subjects 175 
were overweight and 78% (82% of males) were obese. If subjects were classified into 
weight status categories using waist circumference percentiles (centrally overweight >91st, 
centrally obese > 98th percentile) (26, 27) all but three females were classified as obese. 
Ninety percent of subjects identified as overweight by BMI were classified as centrally 
obese by waist percentile, and one female who was obese according to BMI was classified 180 
as centrally overweight based on waist percentile. Twenty-six percent of subjects (42% of 
males) had a waist z-score > 3.5.  
 
Table 3 shows each of the MS indicators by insulin quartiles. Only HDL-C differed by 
gender with higher values in males compared with females, (1.40 (0.25) versus 1.26 (0.23) 185 
mmol/L; p=0.008).  There were significant differences across the insulin quartiles for the 
four metabolic indicators (SBP, TG, TC, HDL-C, all p<0.05) as well as waist z-score 
(P=0.03), but not BMI z-score (p=0.10).  A similar analysis comparing indicators according 
to BMI z-score quartile identified significant differences in waist z-score (p<0.001) and 
insulin (p=0.008) only, and comparison by waist z-score quartile showed significant 190 
differences in BMI z-score (p<0.001) and insulin (p=0.003) only (data not shown).  
 
Table 4 shows the number of subjects identified with abnormal values for metabolic 
indicators used in the six definitions of MS.  No subjects had abnormal fasting glucose 
values.  Additionally, forty-seven percent of subjects had total cholesterol ≥ 4.40 mmol/l 195 
and 43% had an LDL-C cholesterol ≥ 2.85mmol/l. The prevalence of elevated diastolic 
blood pressure defined as > 95th percentile for height, age and gender was low (1%).  The 
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prevalence of these cardiovascular risk factors was neither different by gender nor 
according to presence or absence of MS by any definition.   
 200 
Prevalence of MS was low when applying cut points used in adults, 4% and none of the 
sample respectively for definitions 1 and 2.   Focusing on the child-specific definitions, 
using Definition 3, 60% (54% of males) of subjects were classified with MS.  Fewer 
subjects (39%; 34% of males) were classified with MS using Definition 4 in which the cut 
points for TG and HDL-C are more conservative. The same 39% of subjects were 205 
classified with MS if waist circumference was used instead of BMI (Definition 5).  There 
were no differences in prevalence of MS according to gender but the prevalence of MS did 
increase across insulin quartile regardless of which definition was used (Figure 1, p<0.05). 
There was no difference in presence of MS according to BMI z-score or waist z-score 
quartile using the three child-specific definitions.  MS was present in 48% of overweight 210 
subjects and 63% of obese subjects when Definition 3 was used. The corresponding 
figures for Definition 4 were 29% and 42%. 
 
There were no significant differences in BMI or waist z-scores between those with and 
without MS defined by Definitions 3 and 4 (MS v non MS: BMI z-score = 2.82 v 2.67, waist 215 
z-score = 3.31 v 3.14; p = 0.2). A similar analysis based on Definition 3 alone showed a 
significant difference between the groups in both measures of adiposity (BMI z-score 2.82 
v 2.60 p = 0.03; waist z-score 3.31 v 3.03 p = 0.02). 
 10
Discussion 
In this cross-sectional study of overweight children at entry into a weight management trial, 220 
we have clearly shown the central role of elevated insulin in metabolic disturbance in 
children.  With increasing insulin quartiles, there is an increase in systolic blood pressure, 
fasting triglyceride, total cholesterol, HDL-C and waist z-score, but not BMI z-score.  
Disturbingly, up to 60% of children in this study may be classified with MS, with children in 
the highest insulin quartile more likely to be classified with MS.  The prevalence of MS in 225 
young children depends strongly on the definition chosen, with higher prevalence rates 
estimated if child specific cut points for metabolic indicators were used (39-59%), 
compared to an estimated MS prevalence of 0-4% using adult MS definitions.  In young 
children, use of a MS definition where measures of insulin resistance are not used, 
whether age modified or not, produces a low prevalence of MS.    230 
 
This is the first study in which the variation in MS prevalence according to definition has 
been described in pre-pubertal children.  The findings are consistent with those observed 
in adolescents where agreement between prevalence of MS using 2 adult MS definitions 
was poor (k statistic=0.41) (23).  The lower prevalence of MS estimated in children using 235 
adult definitions compared to variation in adolescents is not unexpected. Limitations of the 
classifications of MS are less likely to occur in adolescents than in younger children as the 
cut points for adolescents will be closer to those of adults. 
 
The MS in adults is associated with increased morbidity and mortality (6). The indicators of 240 
MS are increasingly recognised in adolescence (16, 17, 23, 28); however, there are no 
associated long term morbidity and mortality data available for this age group.  A recent 
US report on MS in adolescents, based on an age-adjusted NCEP definition, suggests that 
the prevalence of MS has risen from 4.2% in 1988-1992 to 6.4% in 1999-2000 (28).  
Studies in children and adolescents aged two to 20 years report varying prevalence rates 245 
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of MS (15, 16, 29).  Our results show  a higher prevalence of MS in an overweight and 
mildly obese sample (39-59%), when compared to estimates of 11-15% using study-
derived cut-points applied to the EGIR definition in a representative community sample of 
Canadian 9-13 year olds (15).  
 250 
The prevalence rates found in our study are similar to those reported by Weiss et al (16) in 
the US and by Viner et al (29) from the UK.  Viner et al applied a WHO-modified definition 
in 103 obese (BMI > 95th percentile) 2-18 year olds and estimated MS prevalence at 33% 
(29).  Weiss et al  defined MS using the EGIR definition (modified using child-specific US 
cut points for MS indicators) in a mixed race US overweight (n=31) and obese (n=439) 255 
population of 4-20 year olds (16).  Prevalence rates varied between 38-49% depending on 
severity of obesity (16).  A notable difference of our study, using the Lambert criteria, to 
that of Weiss and colleagues is that none of the overweight subjects in the Weiss study 
had MS, compared to just over one quarter of overweight subjects in our study, a finding 
which shows how ‘definition-sensitive’ MS prevalence is in childhood (16).   260 
 
These studies on the prevalence of MS in young people raise a number of important 
issues. First, is it possible to define the MS in children and adolescents?  A single 
definition would be invaluable for comparative studies. It is likely that the prevalence of MS 
as defined in adults is uncommon in children, except perhaps in those with more extreme 265 
obesity.  This is borne out by our findings of a low prevalence of MS using adult definitions. 
Prevalence rates based on adult cut points could therefore be presumed to be an 
underestimation, as cut points used to define adult MS are too high for a paediatric 
population.  The use of age-adjusted indicator criteria to define MS in children may allow 
better comparisons with adult prevalence rates which would be important in assessing the 270 
long term evolution of MS and is consistent with the concept of tracking of cardiovascular 
risk factors, many of which are indicators of MS (7-8, 15, 29).  Secondly, there may exist in 
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children a pre-MS condition which can evolve to adult MS and for which intervention 
should be considered. Finally, any MS definition needs to be practical in a clinical setting 
and the necessary age-adjustments, may hinder this requirement. 275 
 
The comparison of MS definitions as performed in this study has not been previously 
described in pre pubertal children. Raised fasting insulin is central to and was the most 
common metabolic disturbance observed in 85% of this overweight and mildly obese 
sample.  Children with hyperinsulinaemia were found to have significantly higher levels of 280 
other common cardiovascular risk factors. This finding confirms that, although group 
average values of these cardiovascular risk factors may still lie within the normal or 
recommended range for age, cardiovascular risk factor values which trend towards 
abnormal are associated with higher insulin levels. In this study, the prevalence of 
individual cardiovascular risk factors was different from that seen in work from the US and 285 
UK (7, 29).  There was a lower prevalence of abnormal TG and a higher prevalence of 
elevated SBP, LDL-C or TC compared to both the US and UK.  There was a lower 
prevalence of abnormal HDL-C versus the US but a higher prevalence versus the UK.  It 
could be postulated that absolute fasting insulin levels in children could be used for early 
detection of a pre-MS.  There is at present no generally accepted clinical definition for 290 
insulin resistance in children, primarily because of limited normative data for either fasting 
or stimulated insulin responses in normal or overweight children and variation in insulin 
level results with different assays. 
 
In this study, weight status, as defined using BMI or waist circumference cut points (19, 295 
26-27), were poor identifiers of MS, even when using age appropriate cut-points 
(Definitions 3, 4 and 5). This is a clinically relevant finding that is in line with other studies 
(30), as it implies the necessity for metabolic risk factor assessment to define a risk 
category in children. An additional finding in our study is the observation that, while 20% of 
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children were identified as overweight using BMI, only 3% of children were classified as 300 
centrally overweight rather than centrally obese using a waist z-score equivalent to < 98th 
percentile and > 91st percentile.  Further study in children is required on a morbidity-related 
definition of overweight using waist circumference, which in adults and probably children, 
is a better predictor than BMI of metabolic risk (6, 30). Higgins et al have suggested a 
single circumference cut point (71cm), not adjusted for age in children (31); we were 305 
unable to confirm the Higgins’ data, as the mean waist circumference of the sample was 
too high. 
 
Hyperinsulinaemia was the most common metabolic abnormality in overweight pre-
pubertal children, yet this is potentially the least likely test to be performed as part of the 310 
medical assessment of such patients.  To our knowledge only one set of national clinical 
obesity management guidelines has addressed the measurement of fasting insulin levels 
in children (32).  In these guidelines assessment of endocrine risk factors in obese children 
is linked to the presence of family risk of overweight and diabetes or clinical signs such as 
acanthosis nigricans. The findings from this study suggest that there is a need to measure 315 
fasting insulin concentration in overweight and obese children, regardless of family history 
of diabetes or ethnic background. This is in agreement with Viner et al who found that 
family history was not related to MS risk (29).  This has implications for screening costs for 
children identified as overweight or obese.  Early detection of hyperinsulinaemia may 
indicate changes in metabolic profile before other more commonly measured 320 
cardiovascular risk factors are outside recommended ranges.  The common or shared 
aetiologies of obesity and MS may also impact on who is targeted for obesity treatment 
and the management approach chosen (33).   
 
The strengths of this study are recent data collection allowing assessment of MS 325 
prevalence within a background of high obesity prevalence and the narrow age range 
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which limits the effect of age-related differences, including the possible confounding of 
puberty on insulin resistance.  The limitations of the study are the lack of a (non-
overweight) control group to enable comparison and that the cut points used for MS 
definitions were not derived from local data.  The cross-sectional design does not allow 330 
comment on how MS indicators evolve over time or what effect the physiological insulin 
resistance of puberty might have on the evolution of MS. 
 
It is difficult to clarify the meaningfulness of the different definitions or make 
recommendations for suitable cut point values.  In the clinical setting, use of a definition 335 
that includes a measure of fasting insulin and uses age-appropriate cut points is important.  
However the need to minimise the number of cut points that must be remembered or 
calculated to make any definition workable highlights that none of those posed here are 
ideal.  There may be other markers suitable as a simple clinical tool for screening of MS 
risk in overweight children.  For example recent work in adults and adolescents show that 340 
CRP, as a marker of systemic inflammation, is a risk factor for type 2 diabetes and CVD, 
and strongly correlates with BMI and insulin levels which can be detected early in life (34-
35).  This is an area that should be considered and further explored in finding a consensus 
for definition of MS in young children.  
 345 
In conclusion, this study emphasises the central role for hyperinsulinaemia in the definition 
of MS in overweight children.    While problematic from a clinical and laboratory 
perspective, there remains a clear need for normal insulin reference ranges to be 
established in children and adolescents over a range of clearly defined weights and 
pubertal status. It is likely that these ranges will need to be assay and population-specific 350 
(36, 37). We agree with Lambert et al that the insulin resistance syndrome (IRS) of 
childhood, or pre-MS, may be a better name than MS in this age group.
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Table 1 Metabolic indicators and cut points included in six definitions used to classify Metabolic Syndrome (MS)  470 
Indicator criteria1  
 Definition of  
Metabolic Syndrome 
Glucose 
(mmol/L)
Triglycerides 
(mmol/L) 
HDL-C  
(mmol/L) 
Systolic  
blood pressure  
(mmHg)  
BMI 
 
Waist 
Circumference 
(cm) 
Insulin 
(pmol/L) 
1 Adult European Group 
for the Study of Insulin 
Resistance (EGIR) (10)2 
6.1 2.03 1.0 3 140 - M4: 94 
F4: 80  
515 
2 Adult US National 
Cholesterol Education 
Program (NCEP) (11)6 
6.1 1.7 1.0 130 - m: 102 
f: 88  
- 
3 Lambert child (15)2 6.1 – 5.9 m: 0.9 
f: 1.00 
m: 1.2 
f:1.2 
P-95% height 7 P-85%8 - m: 35.0  
f: 40.6 
4 Lambert child modified 
(15)2 
6.1-7.9 1.8 0.8 P-95% height 7 P-85%8 - m: 35.0   
f: 40.6 
5 Adult EGIR modified2 6.1-7.9 1.83 0.83 P-95% height 7 - P-91%9 m: 35.0 
f: 40.6 
6 Adult NCEP modified 6 6.1-7.9 1.8 0.8 P-95% height 7 - P-91%9 - 
1 greater than or equal to value except HDL-C for which less than or equal to value 
2 MS present if insulin and any other 2 indicators meet criterion 
3 high triglyceride and/or low HDL-C 
4 m = males, f = females 
5 upper 95% confidence limit of a normal volunteer adult sample from the Endocrinology Laboratory, Royal Prince Alfred Hospital, Sydney (N= 148)  475 
6 MS present if any 3 indicators meet criteria  
7 used P-95% for height as P-75% cut points not available (22)  
8 only 9 y values available; percentile equivalent of these values in UK data determined (20) (m: 1.8, f: 1.5) and extrapolated for all ages  
9 age and gender specific UK waist circumference reference curves (25) 
 480 
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Table 2 Mean (SD) anthropometric characteristics of a sample of 6 to 9 year old 
overweight and mildly obese pre-pubertal children 
 All Boys Girls P value1 
N 99 35 64  
Age (years) 8.3 (1.1) 8.7 (1.0) 8.0 (1.1) <0.01 
Height (cm) 136.4 (8.3) 140.1 (7.8) 134.4 (8.0) <0.01 
Weight (kg) 45.4 (8.9) 48.4 (10.5) 43.8 (7.5) 0.01 
BMI (kg/m2) 24.2 (2.5) 24.4 (3.0) 24.1 (2.3) 0.54 
BMI z-score 2.7 (0.5) 2.8 (0.4) 2.7 (0.5) 0.35 
Waist circumference (cm) 77.2 (7.0) 79.3 (7.6) 76.1 (6.5) 0.03 
Waist z-score 3.2 (0.6) 3.5 (0.7) 3.0 (0.5) <0.01 
1 Significance of independent t-test for comparison by gender 485 
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Table 3 Mean (SD) metabolic and anthropometric characteristics of a sample of 6 to 
9 year old overweight and mildly obese pre-pubertal children 
  Insulin quartile P value1 
 All 1 2 3 4  
N 99 25 26 25 23  
Insulin (pmol/l) 79.9 (37.3) 36.6 (9.4) 65.6 (8.9) 92.0 (9.1) 130.0 (27.2) <0.01 
Systolic BP (mmHg) 116 (11) 111 (9) 116 (12) 116 (11) 120 (9) 0.04 
Diastolic BP (mmHg) 57 (7) 57 (8) 56 (6) 57 (6) 60 (8) 0.19 
Triglyceride (mmol/l) 0.7 (0.6) 0.4 (0.2) 0.6 (0.4) 0.9 (0.7) 1.1 (0.7) <0.01 
Total cholesterol (mmol/l) 4.5 (0.9) 4.1 (0.6) 4.6 (0.7) 4.4 (0.7) 4.9 (1.3) 0.04 
LDL cholesterol (mmol/l) 2.8 (0.8) 2.5 (0.6) 2.9 (0.6) 2.7 (0.6) 3.2 (1.3) 0.07 
HDL cholesterol (mmol/l) 1.3 (0.2) 1.4 (0.2) 1.4 (0.2) 1.2 (0.2) 1.2 (0.2) <0.01 
Glucose (mmol/l) 4.4 (0.8) 4.1 (1.1) 4.5 (0.7) 4.5 (0.5) 4.6 (0.7) 0.16 
BMI z-score2 2.7 (0.5) 2.6 (0.5) 2.7 (0.5) 2.7 (0.4)    2.9 (0.5) 0.10 
Waist z-score3 3.2 (0.6) 3.0 (0.6) 3.1 (0.5) 3.2 (0.6) 3.5 (0.6) 0.03 
1 significance of ANOVA for comparison across quartiles  
2 reference 19  
3 reference 25 490 
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Table 4 Frequency of abnormal values for metabolic indicators and the number of 495 
overweight and mildly obese pre-pubertal children (N=99) classified with metabolic 
syndrome using the six definitions  
Definition Triglyceride  
 
HDL
 
Systolic 
BP  
 
BMI
 
Waist 
circumference  
 
Insulin MS
1 European Group 
for the Study of 
Insulin Resistance 
(EGIR) 1 
3 12 0 na 17 74 4 
2 US National 
Cholesterol 
Education Program 
(NCEP) 2 
5 12 6 na 3 na 0 
3 Lambert1 26 31 41 99 na 85 59 
4 Lambert modified1 3 2 41 99 na 85 39 
5 EGIR modified1 3 2 41 na 99 85 39 
6 NCEP modified2 3 2 41 na 99 na 3 
1 MS present if insulin and any other 2 indicators meet criterion 
2 MS present if any 3 indicators meet criterion 
  500 
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Figure 1 Prevalence of Metabolic Syndrome using five different definitions1, 2 
according to insulin quartile3 in overweight and mildly obese pre-pubertal children 
(N=99)  
 505 
 
 
 
1 see table 1 for details of definitions 
2 Definition 2 not included as no subjects were classified with MS by this definition 510 
3 p<0.05 for increasing prevalence of MS across insulin quartile for definition 1, 3-5 
 
 
 
